Mind Medicine (STU:MMQ) Scaled Net Operating Assets : -0.03 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mind Medicine's operating assets for the quarter that ended in Dec. 2024 was €27.13 Mil. Mind Medicine's operating liabilities for the quarter that ended in Dec. 2024 was €37.10 Mil. Mind Medicine's Total Assets for the quarter that ended in Sep. 2024 was €288.11 Mil. Therefore, Mind Medicine's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was -0.03.

Mind Medicine Scaled Net Operating Assets Historical Data

The historical data trend for Mind Medicine's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Scaled Net Operating Assets Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

-0.05

0.24

0.06

-0.04

-0.09

Mind Medicine Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.05	-0.34	-0.06	-0.03	-0.04

Competitive Comparison of Mind Medicine's Scaled Net Operating Assets

For the Biotechnology subindustry, Mind Medicine's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mind Medicine's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mind Medicine's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Mind Medicine's Scaled Net Operating Assets falls into.

Mind Medicine Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Mind Medicine's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(27.131	-	37.1)	/	114.204
=	-0.09

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	288.554	-	261.423
=	27.131

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	57.971	-	20.871	-	0
=	37.1

Mind Medicine's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(27.131	-	37.1)	/	288.112
=	-0.03

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	288.554	-	261.423
=	27.131

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	57.971	-	20.871	-	0
=	37.1

Mind Medicine Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (STU:MMQ) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

MNMD:USA

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Mind Medicine Headlines

No Headlines